Evaluation of the use, effectiveness and safety of tyrosine kinase inhibitors in chronic myelogenous leukaemia in a general university hospital

  1. Marquinez-Alonso, I.
  2. Escudero-Vilaplana, V.
  3. Osorio, S.
  4. Rodriguez-Gonzalez, C.G.
  5. González-Haba, E.
  6. Sanjurjo-Sáez, M.
Aldizkaria:
European Journal of Hospital Pharmacy

ISSN: 2047-9964 2047-9956

Argitalpen urtea: 2020

Alea: 27

Zenbakia: 5

Orrialdeak: 299-301

Mota: Artikulua

DOI: 10.1136/EJHPHARM-2017-001378 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak